Dipeptidyl Peptidase-4 Inhibitors in the Elderly: More Benefits or Risks?
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dipeptidyl Peptidase-4 Inhibitors in the Elderly: More Benefits or Risks?
Authors
Keywords
-
Journal
ADVANCES IN THERAPY
Volume 29, Issue 3, Pages 218-233
Publisher
Springer Nature
Online
2012-03-12
DOI
10.1007/s12325-012-0008-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Antihyperglycemic Agents Added to Metformin and a Sulfonylurea on Glycemic Control and Weight Gain in Type 2 Diabetes: A Network Meta-analysis
- (2013) Jorge L. Gross ANNALS OF INTERNAL MEDICINE
- Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations
- (2013) Wendy L. Bennett et al. ANNALS OF INTERNAL MEDICINE
- Efficacy and safety of saxagliptin in older patients with type 2 diabetes mellitus
- (2011) Jean Doucet et al. CURRENT MEDICAL RESEARCH AND OPINION
- Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
- (2011) Nir Barzilai et al. CURRENT MEDICAL RESEARCH AND OPINION
- Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials
- (2011) Matteo Monami et al. CURRENT MEDICAL RESEARCH AND OPINION
- Use of Dipeptidyl Peptidase-4 Inhibitors and the Reporting of Infections: A Disproportionality Analysis in the World Health Organization VigiBase
- (2011) M. J. Willemen et al. DIABETES CARE
- Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures: A meta-analysis of randomized clinical trials
- (2011) M. Monami et al. DIABETES CARE
- Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trial
- (2011) V. Lukashevich et al. DIABETES OBESITY & METABOLISM
- Predictors of response to dipeptidyl peptidase-4 inhibitors: evidence from randomized clinical trials
- (2011) Matteo Monami et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study
- (2011) M. Nowicki et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia
- (2011) Roger A. Fielding et al. Journal of the American Medical Directors Association
- Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study
- (2011) Henriette Thisted Horsdal et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Pharmacologic management of the older patient with type 2 diabetes mellitus
- (2010) Joshua J. Neumiller et al. American Journal Geriatric Pharmacotherapy
- Moving against frailty: does physical activity matter?
- (2010) Francesco Landi et al. BIOGERONTOLOGY
- Avoiding hypoglycaemia while achieving good glycaemic control in type 2 diabetes through optimal use of oral agent therapy
- (2010) Anthony H. Barnett CURRENT MEDICAL RESEARCH AND OPINION
- Relationships Between Daily Acute Glucose Fluctuations and Cognitive Performance Among Aged Type 2 Diabetic Patients
- (2010) M. R. Rizzo et al. DIABETES CARE
- Pharmacokinetics of dipeptidylpeptidase-4 inhibitors
- (2010) A. J. Scheen DIABETES OBESITY & METABOLISM
- An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials
- (2010) M. Ligueros-Saylan et al. DIABETES OBESITY & METABOLISM
- Clinical experience with vildagliptin in the management of type 2 diabetes in a patient population ≥75 years: a pooled analysis from a database of clinical trials
- (2010) A. Schweizer et al. DIABETES OBESITY & METABOLISM
- Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis
- (2010) G. Schernthaner et al. DIABETOLOGIA
- Alogliptin
- (2010) Lesley J. Scott DRUGS
- Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes
- (2010) Debora Williams-Herman et al. BMC Endocrine Disorders
- Standards of Medical Care in Diabetes--2010
- (2009) DIABETES CARE
- Comparison of vildagliptin and thiazolidinedione as add-on therapy in patients inadequately controlled with metformin: results of the GALIANT trial - a primary care, type 2 diabetes study
- (2009) L. Blonde et al. DIABETES OBESITY & METABOLISM
- Comparison of vildagliptin and metformin monotherapy in elderly patients with type 2 diabetes: a 24-week, double-blind, randomized trial
- (2009) A. Schweizer et al. DIABETES OBESITY & METABOLISM
- Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials
- (2009) Matteo Monami et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes
- (2009) Carolyn F Deacon et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Neurocognitive impairment and comorbid depression in patients of diabetes mellitus
- (2009) RK Solanki et al. International Journal of Diabetes in Developing Countries
- Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes Mellitus
- (2009) Rachel A. Whitmer JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations
- (2009) Raffaele Marfella et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Key priorities in managing glucose control in older people with diabetes
- (2009) Isabelle Bourdel-Marchasson et al. Journal of Nutrition Health & Aging
- Alogliptin Use in Elderly People: A Pooled Analysis from Phase 2 and 3 Studies
- (2009) Richard E. Pratley et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Prevention of cardiovascular disease through glycemic control in type 2 diabetes: A meta-analysis of randomized clinical trials
- (2009) E. Mannucci et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Dipeptydil peptidase-4 inhibitors in type 2 diabetes: A meta-analysis of randomized clinical trials
- (2009) M. Monami et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- The Growing Burden of Diabetes Mellitus in the US Elderly Population
- (2008) Frank A. Sloan ARCHIVES OF INTERNAL MEDICINE
- Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials
- (2008) Jay S. Skyler et al. CIRCULATION
- Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency
- (2008) J. C. N. Chan et al. DIABETES OBESITY & METABOLISM
- Hypoglycaemia in Type 2 diabetes
- (2008) S. A. Amiel et al. DIABETIC MEDICINE
- New Approaches to Treating Type 2 Diabetes Mellitus in the Elderly
- (2008) Angela M Abbatecola et al. DRUGS & AGING
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search